Icagen and Omdana Therapeutics Announce Collaboration to Pursue Therapies for Patients with Pulmonary Hypertension

 

On June 20, 2017, Icagen, Inc.  and Omdana Therapeutics, Inc. announced a collaboration  to help advance the discovery of novel medicines for disorders related to tissue homeostasis and vascular remodeling such as pulmonary hypertension.  Omdana, a company co-founded by pharma veterans Drs. Christopher VanDeusen and Steve Ledbetter, will partner with Icagen as an integrated drug discovery team with the goal of developing high-quality, advanced leads ready for clinical trials.  

Continue reading